| Term 
 
        | What is depression caused by and how is it treated? |  | Definition 
 
        | -A deficiency of amine neurotransmitters in the brain -Increasing the levels of brain amines (serotonin)
 |  | 
        |  | 
        
        | Term 
 
        | Name four groups of antidepressants. |  | Definition 
 
        | -SSRIs (Selective Serotonin Reuptake Inhibitors) -TCAs (Tricyclic antidepressants)
 -MAOIs (Monoamine Oxidase Inhibitors)
 -Atypical antidepressants
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Fluoxetine (most common) -Paroxetine
 -Sertraline
 |  | 
        |  | 
        
        | Term 
 
        | What is the mechanism of action of SSRIs? |  | Definition 
 
        | They block the neuronal reuptake of serotonin. This leads to a greater concentration of serotonin in the synaptic cleft which compensates for the serotonin deficiency in depressed patients. |  | 
        |  | 
        
        | Term 
 
        | What are SSRIs used for (4)? |  | Definition 
 
        | -Depression -OCD
 -Panic disorder
 -Bulimia and other eating disorders
 |  | 
        |  | 
        
        | Term 
 
        | What are the ADRs of SSRIs (8)? |  | Definition 
 
        | -Nausea -Dry Mouth
 -Diarrhea
 -Nervousness
 -Insomnia
 -Headache
 -Sweating
 -Sexual dysfunction
 |  | 
        |  | 
        
        | Term 
 
        | What is serotinergic syndrome? |  | Definition 
 
        | It is an excess of serotonin in the brain. It can be fatal. SSRIs should not taken with MAOIs for this reason. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Amityriptyline -Imipramine
 |  | 
        |  | 
        
        | Term 
 
        | What is the mechanism of action of TCAs? |  | Definition 
 
        | They block the neuronal reuptake of monoamines. This leads to a greater concentration of NE and serotonin in the synaptic cleft which compensates for MA deficiency in depressed patients. They also increase post-synaptic receptor sensitivity to NE and serotonin which has the same effect. |  | 
        |  | 
        
        | Term 
 
        | What are TCAs used for (6)? |  | Definition 
 
        | -Major depression -Bipolar disorder
 -Dysthymia
 -Atypical depression
 -Some anxiety disorders
 -Pain syndromes
 |  | 
        |  | 
        
        | Term 
 
        | Pharmacokinetics of TCAs (2) |  | Definition 
 
        | -Take orally -Effects usually seen after 3 weeks
 |  | 
        |  | 
        
        | Term 
 
        | Pharmacokinetics of SSRIs (2) |  | Definition 
 
        | -Taken orally once a day -Effects usually seen after 1-4 weeks
 |  | 
        |  | 
        
        | Term 
 
        | What are the ADRs of TCAs (6)? |  | Definition 
 
        | -Orthostatic hypotension -Cardiac effects
 -Anticholinergic effects
 -Sedation
 -OD (narrow TI)
 -Not to be used w/ MAOIs (could cause hypertensive crisis)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Phenelzine -Tranylcypromine
 |  | 
        |  | 
        
        | Term 
 
        | What is the mechanism of action of MAOIs? |  | Definition 
 
        | They irreversibly inhibit the enzyme MAO and prevent the degradation of NE and serotonin. The concentration of NE and serotonin is then, increased. |  | 
        |  | 
        
        | Term 
 
        | What are MAOIs used for (5)? |  | Definition 
 
        | -Atypical depression -Depression that is unresponsive to other treatments
 -Panic disorders
 -OCD
 -Bulimia
 |  | 
        |  | 
        
        | Term 
 
        | Pharmacokinetics of MAOIs (2) |  | Definition 
 
        | -Taken orally -Effects take 2-3 weeks and last up to 2 weeks after stopping treatment
 |  | 
        |  | 
        
        | Term 
 
        | What are the ADRs of MAOIs (6)? |  | Definition 
 
        | -Orthostatic hypotension -Sedation
 -Anticholinergic effects
 -Cardiac effects
 -Risk of OD
 -Interactions with foods that contain tyramine (may cause hypertensive crisis which could result in stroke, coma, or death)
 |  | 
        |  | 
        
        | Term 
 
        | Name two atypical antidepressants. |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | An excess of brain amine neurotransmitters |  | 
        |  | 
        
        | Term 
 
        | Name three anti-mania medications. |  | Definition 
 
        | -Lithium carbonate -Carbamazepine
 -Divalproex
 |  | 
        |  | 
        
        | Term 
 
        | What is the mechanism of action of Lithium? |  | Definition 
 
        | It decreases the release of norepinephrine and dopamine in the CNS. It is used for prevention rather than treatment of acute episodes. |  | 
        |  | 
        
        | Term 
 
        | Pharmacokinetics of Lithium (3) |  | Definition 
 
        | -Taken orally -Half-life of 24-36 hours
 -Not metabolized in the body
 |  | 
        |  | 
        
        | Term 
 
        | What are the ADRs of Lithium (5)? |  | Definition 
 
        | -GI irritation -Risk of gestational malformations
 -Hypothyroidism
 -Renal damage
 -OD (narrow TI)
 |  | 
        |  | 
        
        | Term 
 
        | What are the nursing implications when administering Lithium (10)? |  | Definition 
 
        | -Assess suicide risk -Monitor vital signs
 -Monitor weight
 -Inform patient effects may take weeks
 -Patient should take as ordered, even if feeling better
 -Avoid OTCs
 -Avoid alcohol
 -Avoid driving if drowsy
 -Keep away from children
 -Be careful of drug interactions
 |  | 
        |  |